M.I.TECH Co.Ltd (179290) - Total Liabilities

Latest as of September 2025: ₩13.75 Billion KRW ≈ $9.32 Million USD

Based on the latest financial reports, M.I.TECH Co.Ltd (179290) has total liabilities worth ₩13.75 Billion KRW (≈ $9.32 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 179290 long-term investment intensity to see how much of total assets are deployed in long-term investments.

M.I.TECH Co.Ltd - Total Liabilities Trend (2015–2024)

This chart illustrates how M.I.TECH Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of M.I.TECH Co.Ltd.

M.I.TECH Co.Ltd Competitors by Total Liabilities

The table below lists competitors of M.I.TECH Co.Ltd ranked by their total liabilities.

Company Country Total Liabilities
Baby Bunting Group Ltd
AU:BBN
Australia AU$257.35 Million
Dimerix Ltd
AU:DXB
Australia AU$77.80 Million
Binh Dien Fertilizer JSC
VN:BFC
Vietnam ₫2.27 Trillion
Darya-Varia Laboratoria Tbk
JK:DVLA
Indonesia Rp904.97 Billion
Velo3D, Inc.
NASDAQ:VELO
USA $63.74 Million
Kumho Petro Chemical Co Ltd
KO:011785
Korea ₩2.35 Trillion
Hsinli Chemical Industrial
TWO:4303
Taiwan NT$835.07 Million
Cellectis
PA:ALCLS
France €229.03 Million

Liability Composition Analysis (2015–2024)

This chart breaks down M.I.TECH Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See M.I.TECH Co.Ltd (179290) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 9.48 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.11 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.10 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how M.I.TECH Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for M.I.TECH Co.Ltd (2015–2024)

The table below shows the annual total liabilities of M.I.TECH Co.Ltd from 2015 to 2024.

Year Total Liabilities Change
2024-12-31 ₩9.70 Billion
≈ $6.57 Million
+64.24%
2023-12-31 ₩5.90 Billion
≈ $4.00 Million
-43.78%
2022-12-31 ₩10.50 Billion
≈ $7.12 Million
-23.71%
2021-12-31 ₩13.76 Billion
≈ $9.33 Million
+8.55%
2020-12-31 ₩12.68 Billion
≈ $8.59 Million
+39.93%
2019-12-31 ₩9.06 Billion
≈ $6.14 Million
+101.71%
2018-12-31 ₩4.49 Billion
≈ $3.04 Million
-59.12%
2017-12-31 ₩10.99 Billion
≈ $7.45 Million
+191.39%
2016-12-31 ₩3.77 Billion
≈ $2.56 Million
+50.88%
2015-12-31 ₩2.50 Billion
≈ $1.69 Million
--

About M.I.TECH Co.Ltd

KQ:179290 Korea Medical Instruments & Supplies
Market Cap
$103.97 Million
₩153.41 Billion KRW
Market Cap Rank
#19150 Global
#934 in Korea
Share Price
₩4740.00
Change (1 day)
-2.87%
52-Week Range
₩4195.00 - ₩7810.00
All Time High
₩15478.41
About

M.I.TECH Co.,Ltd engages in the provision of various medical devices in South Korea. The company offers HANAROSTENT, a non-vascular stent; and glucometers under the GBIO BASE and RAPICHECK brand names. It also provides beauty systems, such as BRT system which is used in cleansing skin and inject the effective component in non-invasive way; and ClearView which is used in injecting the effective co… Read more